Merck Study and Cost Savings

Ex-Google Duplex Eng Lead on Disrupting $2B Clinical Trials with AI - Patrick Leung

Topic 8 of 18

Published Jul 28, 2025 · Clip 18:50–21:28 (2:37)

Patrick explains that small upfront design changes on decade-long projects yield huge savings. A published study with Merck found that using Faro Study Designer saved north of $100 million over a trial's lifetime—before AI writing features. Faster time to market is worth hundreds of thousands of dollars per day in revenue, and the technology could enable smaller players and more treatments by widening the trial pipeline.